New Zealand markets open in 9 hours 34 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.29-0.43 (-7.52%)
At close: 04:00PM EDT
5.14 -0.15 (-2.84%)
After hours: 07:03PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.72
Open5.61
Bid5.10 x 800
Ask5.31 x 800
Day's range5.20 - 5.69
52-week range2.91 - 12.50
Volume659,752
Avg. volume525,609
Market cap407.155M
Beta (5Y monthly)1.44
PE ratio (TTM)N/A
EPS (TTM)-1.02
Earnings date07 Nov 2022 - 11 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.79
  • Business Wire

    Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting

    BEDFORD, Mass., September 22, 2022--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced multiple presentations at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting being held September 30 - October 3, 2022 at McCormick Place Convention Center in Chicago, IL.

  • Business Wire

    Ocular Therapeutix™ to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    BEDFORD, Mass., September 07, 2022--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 at 11:00 AM ET at the Lotte New York Palace Hotel in New York, NY.

  • Business Wire

    Ocular Therapeutix™ to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

    BEDFORD, Mass., August 10, 2022--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on Wednesday, August 17, 2022: